Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

USA - NYSE:ICL - IL0002810146 - Common Stock

6.28 USD
+0.06 (+0.96%)
Last: 10/17/2025, 8:19:53 PM
6.28 USD
0 (0%)
After Hours: 10/17/2025, 8:19:53 PM
Fundamental Rating

5

ICL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. While ICL has a great profitability rating, there are some minor concerns on its financial health. ICL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ICL had positive earnings in the past year.
ICL had a positive operating cash flow in the past year.
Each year in the past 5 years ICL has been profitable.
ICL had a positive operating cash flow in each of the past 5 years.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

ICL has a better Return On Assets (2.97%) than 63.86% of its industry peers.
The Return On Equity of ICL (6.10%) is better than 67.47% of its industry peers.
ICL's Return On Invested Capital of 5.24% is fine compared to the rest of the industry. ICL outperforms 60.24% of its industry peers.
ICL had an Average Return On Invested Capital over the past 3 years of 13.86%. This is significantly above the industry average of 6.30%.
The last Return On Invested Capital (5.24%) for ICL is well below the 3 year average (13.86%), which needs to be investigated, but indicates that ICL had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROIC 5.24%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

With a decent Profit Margin value of 5.28%, ICL is doing good in the industry, outperforming 71.08% of the companies in the same industry.
ICL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 10.46%, ICL is in the better half of the industry, outperforming 60.24% of the companies in the same industry.
In the last couple of years the Operating Margin of ICL has declined.
ICL has a better Gross Margin (32.29%) than 61.45% of its industry peers.
In the last couple of years the Gross Margin of ICL has remained more or less at the same level.
Industry RankSector Rank
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ICL is creating value.
ICL has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ICL has been increased compared to 5 years ago.
The debt/assets ratio for ICL has been reduced compared to a year ago.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ICL has an Altman-Z score of 2.37. This is not the best score and indicates that ICL is in the grey zone with still only limited risk for bankruptcy at the moment.
ICL has a better Altman-Z score (2.37) than 67.47% of its industry peers.
The Debt to FCF ratio of ICL is 6.12, which is on the high side as it means it would take ICL, 6.12 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 6.12, ICL is doing good in the industry, outperforming 75.90% of the companies in the same industry.
ICL has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ICL has a better Debt to Equity ratio (0.42) than 71.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Altman-Z 2.37
ROIC/WACC0.69
WACC7.57%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.75 indicates that ICL should not have too much problems paying its short term obligations.
ICL has a worse Current ratio (1.75) than 60.24% of its industry peers.
A Quick Ratio of 1.05 indicates that ICL should not have too much problems paying its short term obligations.
The Quick ratio of ICL (1.05) is worse than 63.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.05
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

ICL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.50%.
The Revenue has decreased by -1.22% in the past year.
Measured over the past years, ICL shows a small growth in Revenue. The Revenue has been growing by 5.35% on average per year.
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%

3.2 Future

ICL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.46% yearly.
ICL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.13% yearly.
EPS Next Y-1.04%
EPS Next 2Y10.53%
EPS Next 3Y11.46%
EPS Next 5YN/A
Revenue Next Year3.8%
Revenue Next 2Y4.5%
Revenue Next 3Y4.13%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.97, ICL is valued correctly.
61.45% of the companies in the same industry are more expensive than ICL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.40. ICL is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 13.53, the valuation of ICL can be described as correct.
Based on the Price/Forward Earnings ratio, ICL is valued a bit cheaper than 62.65% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, ICL is valued a bit cheaper.
Industry RankSector Rank
PE 16.97
Fwd PE 13.53
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

72.29% of the companies in the same industry are more expensive than ICL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ICL is valued a bit cheaper than 72.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.03
EV/EBITDA 7.64
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of ICL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.53%
EPS Next 3Y11.46%

3

5. Dividend

5.1 Amount

ICL has a Yearly Dividend Yield of 2.79%.
ICL's Dividend Yield is a higher than the industry average which is at 3.69.
ICL's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of ICL decreases each year by -1.81%.
ICL has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

64.85% of the earnings are spent on dividend by ICL. This is not a sustainable payout ratio.
DP64.85%
EPS Next 2Y10.53%
EPS Next 3Y11.46%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (10/17/2025, 8:19:53 PM)

After market: 6.28 0 (0%)

6.28

+0.06 (+0.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners25.14%
Inst Owner Change-0.81%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap8.11B
Analysts47.5
Price Target0.02 (-99.68%)
Short Float %0.23%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend0.19
Dividend Growth(5Y)-1.81%
DP64.85%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-03 2025-09-03 (0.1442436)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.62%
Min EPS beat(2)-18.25%
Max EPS beat(2)-0.99%
EPS beat(4)2
Avg EPS beat(4)1.71%
Min EPS beat(4)-18.25%
Max EPS beat(4)25.18%
EPS beat(8)6
Avg EPS beat(8)9.5%
EPS beat(12)7
Avg EPS beat(12)6.24%
EPS beat(16)11
Avg EPS beat(16)18.56%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-69.87%
PT rev (3m)-68.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.06%
EPS NY rev (1m)2.43%
EPS NY rev (3m)-14.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 16.97
Fwd PE 13.53
P/S 1.17
P/FCF 17.03
P/OCF 6.26
P/B 1.35
P/tB 1.6
EV/EBITDA 7.64
EPS(TTM)0.37
EY5.89%
EPS(NY)0.46
Fwd EY7.39%
FCF(TTM)0.37
FCFY5.87%
OCF(TTM)1
OCFY15.96%
SpS5.39
BVpS4.66
TBVpS3.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROCE 7.31%
ROIC 5.24%
ROICexc 5.64%
ROICexgc 6.28%
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
FCFM 6.85%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ROICexc(3y)14.67%
ROICexc(5y)11.45%
ROICexgc(3y)16.24%
ROICexgc(5y)12.7%
ROCE(3y)19.96%
ROCE(5y)15.59%
ROICexcg growth 3Y-15.7%
ROICexcg growth 5Y-1.81%
ROICexc growth 3Y-15.48%
ROICexc growth 5Y-2.08%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Debt/EBITDA 1.92
Cap/Depr 136.79%
Cap/Sales 11.76%
Interest Coverage 6.21
Cash Conversion 97.66%
Profit Quality 129.7%
Current Ratio 1.75
Quick Ratio 1.05
Altman-Z 2.37
F-Score5
WACC7.57%
ROIC/WACC0.69
Cap/Depr(3y)138.38%
Cap/Depr(5y)133.57%
Cap/Sales(3y)9.41%
Cap/Sales(5y)9.89%
Profit Quality(3y)123.56%
Profit Quality(5y)409.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
EPS Next Y-1.04%
EPS Next 2Y10.53%
EPS Next 3Y11.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%
Revenue Next Year3.8%
Revenue Next 2Y4.5%
Revenue Next 3Y4.13%
Revenue Next 5YN/A
EBIT growth 1Y-7.97%
EBIT growth 3Y-13.49%
EBIT growth 5Y0.95%
EBIT Next Year68.18%
EBIT Next 3Y25.41%
EBIT Next 5YN/A
FCF growth 1Y-57.35%
FCF growth 3Y18.48%
FCF growth 5Y12.66%
OCF growth 1Y-29.9%
OCF growth 3Y11.29%
OCF growth 5Y8.15%